Jessica P. Bousquet

Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Journal: Allergy

Published: January 21, 2026

Sensitisation patterns and burden of uncontrolled respiratory allergy symptoms in military personnel.

Sensitisation patterns and burden of uncontrolled respiratory allergy symptoms in military personnel.

Journal: BMJ military health

Published: March 21, 2025

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal: Journal of investigational allergology & clinical immunology

Published: January 23, 2025

Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper.

Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper.

Journal: Allergy

Published: December 12, 2024

Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.

Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.

Journal: Journal of investigational allergology & clinical immunology

Published: September 25, 2024

Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.

Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.

Journal: Journal of investigational allergology & clinical immunology

Published: May 15, 2024

Back to the roots of medicine: It's severe asthma patient-reported symptoms that matter!

Back to the roots of medicine: It's severe asthma patient-reported symptoms that matter!

Journal: Pulmonology

Published: September 14, 2023

Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

Journal: Pulmonology

Published: August 05, 2023

From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).

From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).

Journal: Journal of investigational allergology & clinical immunology

Published: July 27, 2023

Letter to the Editor: Launch of a 2022-2024 National Plan Against Falls in Older Persons in France.

Letter to the Editor: Launch of a 2022-2024 National Plan Against Falls in Older Persons in France.

Journal: The journal of nutrition, health & aging

Published: May 12, 2023

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Journal: Allergy

Published: September 10, 2022

Asthma hospitalizations: A call for a national strategy to fight health inequities.

Asthma hospitalizations: A call for a national strategy to fight health inequities.

Journal: Pulmonology

Published: August 22, 2022

Showing 1-12 of 131

Last Updated: 09/26/2026